The American Academy of Pain Medicine has recognized mesenchymal stem cell [MSC] treatments as a viable method to block opioid-induced tolerance. The Academy cites a study done by the Cleveland Clinic in which the development of opioid tolerance was effectively prevented by either intravenous or intrathecal MSCs. Furthermore, established opioid tolerance was reversed when the timing of the transplants followed repeated morphine injections.
“This emerging therapy has enormous potential to profoundly impact clinical practice. It may improve the efficacy of opioid therapy, reduce the risk of opioid overdose and save lives,” said Jianguo Cheng, MD, PhD, professor of anesthesiology and director of the Cleveland Clinic Pain Medicine Fellowship Program.
The Cleveland Clinic’s research is an example of the potential for stem cells to impact the efficacy of treatments for a wide variety conditions. To learn more about stem cells and how to insure access to emerging personalized regenerative treatments by banking your own valuable dental pulp stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.